Leucine-Rich Alpha-2 Glycoprotein 1 (LRG1) and Proangiogenic Mediators in Sickle Cell Disease.
作者信息
Kleebayoon Amnuay, Wiwanitkit Viroj
机构信息
Private Academic Consultant, Samraong, Cambodia
Saveetha Institute of Medical and Technical Sciences (Deemed to be University) Saveetha Dental College, Chennai, India
出版信息
Turk J Haematol. 2025 Aug 29;42(3):253-255. doi: 10.4274/tjh.galenos.2025.2025.0262. Epub 2025 Jul 22.
Abstract
摘要
相似文献
1
Leucine-Rich Alpha-2 Glycoprotein 1 (LRG1) and Proangiogenic Mediators in Sickle Cell Disease.
Turk J Haematol. 2025 Aug 29;42(3):253-255. doi: 10.4274/tjh.galenos.2025.2025.0262. Epub 2025 Jul 22.
2
Exploration of Leucine-Rich Alpha-2 Glycoprotein 1 (LRG1) and Its Association with Proangiogenic Mediators in Sickle Cell Disease: A Potential Player in the Pathogenesis of the Disease.
Turk J Haematol. 2025 May 22;42(2):100-107. doi: 10.4274/tjh.galenos.2025.2025.0441. Epub 2025 Apr 15.
3
Biological role and clinicopathological significance of leucine-rich α-2 glycoprotein 1 in the glioblastoma microenvironment.
J Neuropathol Exp Neurol. 2025 Aug 1;84(8):707-714. doi: 10.1093/jnen/nlaf049.
4
Leucine-rich alpha-2-glycoprotein 1 (LRG1) decrement during biologics therapy and its correlation with disease features and treatment outcomes in rheumatoid arthritis patients.
Clin Rheumatol. 2025 Jul 15. doi: 10.1007/s10067-025-07545-2.
5
The role of leucine-rich alpha-2-glycoprotein-1 in proliferation, migration, and invasion of tumors.
J Cancer Res Clin Oncol. 2022 Feb;148(2):283-291. doi: 10.1007/s00432-021-03876-0. Epub 2022 Jan 17.
6
Serum leucine-rich α-2 glycoprotein 1 predicts 10-year mortality and vascular events in coronary angiography patients.
Atherosclerosis. 2025 Aug;407:120413. doi: 10.1016/j.atherosclerosis.2025.120413. Epub 2025 Jun 20.
7
Double product is longitudinally associated with reduced cognitive function in type 2 diabetes with insights from cross-lagged panel analysis and mediation by leucine-rich α-2-glycoprotein 1.
J Alzheimers Dis. 2025 Jul;106(2):668-677. doi: 10.1177/13872877251344881. Epub 2025 Jul 1.
8
Early Enhanced Leucine-Rich -2-Glycoprotein-1 Expression in Glomerular Endothelial Cells of Type 2 Diabetic Nephropathy Model Mice.
Biomed Res Int. 2018 Nov 1;2018:2817045. doi: 10.1155/2018/2817045. eCollection 2018.
9
Serum levels of leucine-rich α-2 glycoprotein 1 (LRG1), pro-neurotensin (PNT), fatty acid-binding protein 4 (FABP4) and furin in pediatric growth hormone deficiency before and after 1-year growth hormone replacement therapy.
Cytokine. 2025 Nov;195:157022. doi: 10.1016/j.cyto.2025.157022. Epub 2025 Aug 28.
10
Plasma leucine-rich α-2-glycoprotein 1 - a novel marker of diabetic kidney disease in children and adolescents with type 1 diabetes mellitus?
Pediatr Nephrol. 2023 Dec;38(12):4043-4049. doi: 10.1007/s00467-023-06019-4. Epub 2023 Jul 4.
本文引用的文献
1
Exploration of Leucine-Rich Alpha-2 Glycoprotein 1 (LRG1) and Its Association with Proangiogenic Mediators in Sickle Cell Disease: A Potential Player in the Pathogenesis of the Disease.
Turk J Haematol. 2025 May 22;42(2):100-107. doi: 10.4274/tjh.galenos.2025.2025.0441. Epub 2025 Apr 15.
2
The disruptive role of LRG1 on the vasculature and perivascular microenvironment.
Front Cardiovasc Med. 2024 Apr 30;11:1386177. doi: 10.3389/fcvm.2024.1386177. eCollection 2024.
3
Research Progress on Leucine-Rich Alpha-2 Glycoprotein 1: A Review.
Front Pharmacol. 2022 Jan 5;12:809225. doi: 10.3389/fphar.2021.809225. eCollection 2021.
4
Inflammatory molecule reduction with hydroxyurea therapy in children with sickle cell anemia.
Haematologica. 2018 Feb;103(2):e50-e54. doi: 10.3324/haematol.2017.177360. Epub 2017 Nov 16.
5
Leucine Rich α-2 Glycoprotein: A Novel Neutrophil Granule Protein and Modulator of Myelopoiesis.
PLoS One. 2017 Jan 12;12(1):e0170261. doi: 10.1371/journal.pone.0170261. eCollection 2017.
6
HIF-1 mediates pathogenic inflammatory responses to intestinal ischemia-reperfusion injury.
Am J Physiol Gastrointest Liver Physiol. 2010 Oct;299(4):G833-43. doi: 10.1152/ajpgi.00065.2010. Epub 2010 Aug 5.
Zotero 插件